Form 4 for BMY Bristol Myers Squibb
Accepted 2023-05-04 00:00:00 ET · period of report 2023-05-03 · accession 0000014272-23-000114 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-05-04 | 2023-05-03 | BMY | VESSEY RUPERT | EVP, Pres, Research | S - Sale | $67.06 | -50.4K | 47.8K | -51% | -$3.38M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, $0.10 par value | 2023-05-03 | S | D | 50,385 | $67.06 | 47,751 | D | — | — | (F1) The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $67.050 to $67.111, inclusive. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. |